S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH VENETOCLAX IN TREATMENT-NAÏVE HIGHER-RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA

• Alex Bataller,
• Alexandre Bazinet,
• Sangeetha Venugopal,
• Guillermo Montalban-Bravo,
• Yesid Alvarado,
• Kelly Chien,
• Ghayas Issa,
• Nicholas Short,
• Danielle Hammond,
• Lucia Masarova,
• Tapan Kadia,
• Rashmi Kanagal-Shamanna,
• Stephany Hendrickson,
• Farhad Ravandi,
• Elias Jabbour,
• Hagop Kantarjian,
• Guillermo Garcia-Manero

Affiliations

Alex Bataller

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Alexandre Bazinet

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Sangeetha Venugopal

2 Sylvester Comprehensive Cancer Center, Miami, United States

Guillermo Montalban-Bravo

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Yesid Alvarado

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Kelly Chien

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Ghayas Issa

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Nicholas Short

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Danielle Hammond

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Lucia Masarova

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Tapan Kadia

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Rashmi Kanagal-Shamanna

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Stephany Hendrickson

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Farhad Ravandi

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Elias Jabbour

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Hagop Kantarjian

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Guillermo Garcia-Manero

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States